Point-of-Care Testing gains ground with BD’s acquisition of Alverix
In 2007, Alverix set out to revolutionize point-of-care (POC) testing–medical tests conducted in the doctor’s office, at a patient’s bedside, in a clinic or even…
Posted by
In 2007, Alverix set out to revolutionize point-of-care (POC) testing–medical tests conducted in the doctor’s office, at a patient’s bedside, in a clinic or even…
Posted by
In February 2011—long before the term “Internet of Things” became a hot business buzzword—Safeguard Scientifics saw potential in ThingWorx, the first application platform that lets…
Posted by
During my nearly five years at Safeguard, I’ve worked closely with my predecessor, Peter Boni, and the current management team to define our strategy and…
Posted by
This morning, I presented at the 2012 Annual RBC Biotech Conference, which focused on the “Biotech Success Stories of the [Philadelphia] Region”. I was asked…
Posted by
This morning, we announced Safeguard Scientifics’ second quarter 2012 results and reported on developments at Safeguard and our partner companies, which included customer wins, strategic…
Posted by
The convergence of technology and healthcare attracted significant new attention last year, according to research from Dow Jones VentureSource. In 2011, VCs poured $439 million…
Posted by
This morning, we announced our fourth quarter and full-year 2011 financial results. Consolidated net loss for the three months ended December 31, 2011 was $24.5…
Posted by
As 2011 comes to a close, it offers us an opportunity to look back at the major milestones and key events of the year. While…
Posted by
Socrates believed that persistence—above trust, genius, or education—was the characteristic that most frequently led to success. I’ve adhered to that philosophy since I first read…
Posted by